Sanofi announced an expansion of its partnership with McLaren Racing. The two companies, alongside United Autosports, are ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

Quarterly Net Profit at Rs. 50.00 crore in March 2025 down 20.26% from Rs. 62.70 crore in March 2024. EBITDA stands at Rs. 69 ...

France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its ...

Merck KGaA to buy Springworks for $3.9 billion Merck KGaA (OTCPK:MKGAF) is set to acquire SpringWorks Therapeutics (SWTX) for ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to ...

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma ...

Sanofi is racing to raise the flag on meningitis awareness—literally. | This year's 24 Hours of Le Mans endurance car race in ...

The company reiterated its financial outlook for the year but is struggling to predict the likely impact of pharmaceutical ...

The results came after the close of the market hours. Shares of Sanofi Consumer Healthcare India Ltd ended at ₹4,940.00, down ...

McLaren partner team United Autosports will race at Le Mans 24 Hours next month with a special one-off livery on its No. 59 ...

New Delhi: SanofiHealthcare India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the trial of the drug ...